← Taiwan Stock Snapshot Database

Home / Indicator library / Biotechnology and Medical Care / BORA (6472) overview

BORA (6472) stock overview

Valuation, financials, growth, ownership, events, dividends, models and adjusted prices for BORA, on one page

中文版 (Chinese)

BORA (6472) snapshot, key figures

Price / earnings
31.42x
Price / book
3.47x
Dividend yield
2.52%
Revenue YoY (2026-06)
39.2%
Monthly revenue (2026-06)
TWD 2.30bn
Sector
Biotechnology and Medical Care
Listing venue
Taiwan Stock Exchange
Values above are the official-source snapshot for BORA (6472) on 2026-08-03. We do not chase live quotes. Every trading day is frozen as its own point-in-time vintage, so a backtest reading this data sees only what was actually knowable that day, with no look-ahead bias. Missing values stay blank. Nothing is interpolated or extrapolated.

BORA (6472): where today sits in the past year

Current value against the 2025-07-31 to 2026-07-31 range, built from 243 frozen daily vintages.

Price / earnings31.42x88th percentile of the past year
15.39xmedian 19.08x35.14x
Price / book3.47x21st percentile of the past year
2.94xmedian 4.62x6.83x
Dividend yield2.52%53rd percentile of the past year
1.93%median 2.50%3.54%
The marker is today's value; the faint tick is the one-year median. Every point in this range is the number as it was published on its own date, never a restated figure, so the percentile is what a reader on that day could actually have computed. Ratios at or below zero are excluded rather than treated as cheap. Tickers with fewer than 60 observed dates get no range at all.
Loading checkup signals…

Seven-dimension checkup for this ticker →

Valuation river

Loading…

Financial quality

Loading…

Revenue growth

Loading…

Ownership structure

Loading…

Events, last 90 days

Loading…

Yield river

Loading…

Valuation models

Loading…

Adjusted-price candles

Loading…

6472: common questions

What is 6472's P/E ratio?

6472 traded at a price-to-earnings ratio of 31.42x in the official-source snapshot dated 2026-08-03. That figure is frozen as a point-in-time vintage, so a backtest reading it sees only what was knowable that day.

What is 6472's price-to-book ratio?

6472's price-to-book ratio was 3.47x on 2026-08-03, taken as-is from the official public source.

What is 6472's dividend yield?

6472's cash dividend yield was 2.52% on 2026-08-03. Historical dividend policy and gap-fill records are available on the same page.

How fast is 6472's revenue growing?

6472 reported 39.2% year-on-year monthly revenue growth for 2026-06, from the official monthly revenue filing.

Is 6472's price / earnings high or low right now?

6472's price / earnings is 31.42x, which is above its one-year median of 19.08x and sits at the 88th percentile of the 15.39–35.14x range observed over the last 243 snapshot dates. Each of those dates is a frozen point-in-time vintage, so the range contains no restated or back-filled values.

Is 6472's price / book high or low right now?

6472's price / book is 3.47x, which is below its one-year median of 4.62x and sits at the 21st percentile of the 2.94–6.83x range observed over the last 243 snapshot dates. Each of those dates is a frozen point-in-time vintage, so the range contains no restated or back-filled values.

Other Biotechnology and Medical Care tickers

160 Taiwan-listed tickers sit in this sector. See the full Biotechnology and Medical Care table.

Everything on this page is either the official public source shown as-is, or a transparent derivation you can reproduce. The free tier covers 2330 in full as a reference case; on other tickers some blocks are paid-tier. What we sell is data and tooling, not investment advice, not stock tips, and not a promise of returns.